Targeting tumor plasticity to combat immune evasion in liver cancer – Terence K. Lee from The Hong Kong Polytechnic University, Hong Kong SAR, China, previously reported on the roles of CD24 and CD47 as potential markers for liver cancer stem cells, functioning as “don’t eat me” signals, effectively suppressing immune responses in HCC. The gene discussed is CD24; the disease is liver cancer.